TrialDrug and alcohol dependence2009

Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone.

R Douglas Bruce et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.